• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Natural Camphor

European Union chaplet of stars
General Notices

(d-Camphor, Ph Eur monograph 1400)

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_1_2010_70_cs.png


C10H16O    152.2    464-49-3

Ph Eur

DEFINITION

(1R,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one.

CHARACTERS
Appearance

White or almost white, crystalline powder or friable, crystalline masses.

Highly volatile even at room temperature.

Solubility

Slightly soluble in water, very soluble in alcohol and in light petroleum, freely soluble in fatty oils, very slightly soluble in glycerol.

IDENTIFICATION

First identification  A, C.

Second identification  A, B, D.

A. Specific optical rotation (see Tests).

B. Melting point (2.2.14): 175 °C to 179 °C.

C. Infrared absorption spectrophotometry (2.2.24).

Comparison  racemic camphor CRS.

D. Dissolve 1.0 g in 30 mL of methanol R. Add 1.0 g of hydroxylamine hydrochloride R and 1.0 g of anhydrous sodium acetate R. Boil under a reflux condenser for 2 h. Allow to cool and add 100 mL of water R. Filter, wash the precipitate obtained with 10 mL of water R and recrystallise from 10 mL of a mixture of 4 volumes of alcohol R and 6 volumes of water R. The crystals, dried in vacuo, melt (2.2.14) at 118 °C to 121 °C.

TESTS

Carry out the weighings and dissolution rapidly.

Solution S

Dissolve 2.50 g in 10 mL of alcohol R and dilute to 25.0 mL with the same solvent.

Appearance of solution

Solution S is clear (2.2.1) and colourless (2.2.2, Method II).

Acidity or alkalinity

To 10 mL of solution S add 0.1 mL of phenolphthalein solution R1. The solution is colourless. Not more than 0.2 mL of 0.1 M sodium hydroxide is required to change the colour of the indicator.

Specific optical rotation (2.2.7)

+ 40.0 to + 43.0, determined on solution S.

Related substances

Gas chromatography (2.2.28).

Test solution  Dissolve 2.50 g of the substance to be examined in heptane R and dilute to 25.0 mL with the same solvent.

Reference solution (a)  Dilute 1.0 mL of the test solution to 100.0 mL with heptane R.

Reference solution (b)  Dilute 10.0 mL of reference solution (a) to 20.0 mL with heptane R.

Reference solution (c)  Dissolve 0.50 g of borneol R in heptane R and dilute to 25.0 mL with the same solvent. Dilute 5.0 mL of the solution to 50.0 mL with heptane R.

Reference solution (d)  Dissolve 50 mg of linalol R and 50 mg of bornyl acetate R in heptane R and dilute to 100.0 mL with the same solvent.

Column:
  • size: l = 30 m, Ø = 0.25 mm,

Carrier gas  helium for chromatography R.

Split ratio  1:70.

Flow rate  45 cm/s.

Temperature:

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_2_2010_70_tb.png


Detection  Flame ionisation.

Injection  1 µL.

System suitability  Reference solution (d).

  • resolution: minimum 3.0 between the peaks due to bornyl acetate and to linalol.
Limits:
  • borneol: not more than the area of the principal peak in the chromatogram obtained with reference solution (c) (2.0 per cent),
  • any other impurity: not more than half of the area of the principal peak in the chromatogram obtained with reference solution (a) (0.5 per cent),
  • total of other impurities: not more than 4 times the area of the principal peak in the chromatogram obtained with reference solution (a) (4.0 per cent),
  • disregard limit: 0.1 times the area of the principal peak in the chromatogram obtained with reference solution (b) (0.05 per cent).
Halogens

Maximum 100 ppm.

Dissolve 1.0 g in 10 mL of 2-propanol R in a distillation flask. Add 1.5 mL of dilute sodium hydroxide solution R and 50 mg of nickel-aluminium alloy R. Heat on a water-bath until the 2-propanol R has evaporated. Allow to cool and add 5 mL of water R. Mix and filter through a wet filter previously washed with water R until free from chlorides. Dilute the filtrate to 10.0 mL with water R. To 5.0 mL of the solution, add nitric acid R dropwise until the precipitate which forms is redissolved and dilute to 15 mL with water R. The solution complies with the limit test for chlorides (2.4.4).

Residue on evaporation (2.8.9)

Maximum 0.05 per cent.

Evaporate 2.0 g on a water-bath and dry in an oven at 100-105 °C for 1 h. The residue weighs a maximum of 1 mg.

Water

Dissolve 1 g in 10 mL of light petroleum R. The solution is clear (2.2.1).

IMPURITIES

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_3_2010_70_cs.png


A. 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene (α-pinene),

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_4_2010_70_cs.png


B. 2,2-dimethyl-3-methylenebicyclo[2.2.1]heptane (camphene),

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_5_2010_70_cs.png


C. 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane (β-pinene),

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_6_2010_70_cs.png


D. 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane (cineole),

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_7_2010_70_cs.png


E. R1 = CH3, R2 + R3 = O: 1,3,3-trimethylbicyclo[2.2.1]heptan-2-one (fenchone),

F. R1 = CH3, R2 = OH, R3 = H: exo-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol (fenchol),

G. R1 = H, R2 = OH, R3 = CH3: exo-2,3,3-trimethylbicyclo[2.2.1]heptan-2-ol (camphene hydrate),

H. R1 = H, R2 = CH3, R3 = OH: endo-2,3,3-trimethylbicyclo[2.2.1]heptan-2-ol (methylcamphenilol),

bp2012_v1_07_medicinal_and_pharmaceutical_substances_3 dcamphor_8_2010_70_cs.png


I. R = OH, R′ = H: exo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol (exo-borneol),

J. R = H, R′ = OH: endo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol (endo-borneol).

Ph Eur